پارس دارو
دپارس | Stocks - Tehran Stock Exchange (TSE)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
Authorized
Last Price: 62,110 2.98
Close Price: 61,750
Income Statement
AGM
Interim
2026/08/16 Fiscal Year 2026/03/2012 Month | 2025/07/14 Fiscal Year 2025/03/2012 Month | 2024/07/03 Fiscal Year 2024/03/1912 Month | ||
|---|---|---|---|---|
Revenue from Services & Sales | 24.105 Trillion | 16.546 Trillion | 12.105 Trillion | |
Total Revenues | 24.105 Trillion | 16.546 Trillion | 12.105 Trillion | |
Cost of Goods Sold | 14.551 Trillion | 9.991 Trillion | 6.114 Trillion | |
Gross Profit | 9.554 Trillion | 6.555 Trillion | 5.991 Trillion | |
General & Administrative Expenses | 1.511 Trillion | 1.09 Trillion | 585.312 Billion | |
Net Operating Income & Expenses | 5.448 Trillion | 5.329 Trillion | -8.262 Billion | |
Operating Profit (Loss) | 13.491 Trillion | 10.794 Trillion | 5.398 Trillion | |
Profit Before Tax | 13.116 Trillion | 12.906 Trillion | 8.599 Trillion | |
Tax | 1.466 Trillion | 1.105 Trillion | 1.075 Trillion | |
Net Profit (Loss) After Tax | 11.65 Trillion | 11.801 Trillion | 7.524 Trillion | |
Retained Earnings at Beginning of Period | 14.851 Trillion | 8.322 Trillion | 7.989 Trillion | |
Approved Dividends — Prior Year AGM | -11.448 Trillion | -5.273 Trillion | -7.191 Trillion | |
Allocable Profit | 15.053 Trillion | 14.851 Trillion | 8.322 Trillion | |
Legal Reserve | 150 Billion | 95 Billion | - | |
Approved Dividends — Current Year | 7.999 Trillion | 11.448 Trillion | 5.273 Trillion | |
Retained Earnings at End of Period | 6.904 Trillion | 3.308 Trillion | 3.05 Trillion |